Google’s artificial intelligence arm breaks into healthcare

 
DeepMind, Google’s artificial intelligence arm, has plans to break into healthcare via a new partnership with Imperial College London and the Royal Free London National Health Services Foundation Trust, according to a BloombergBusiness report.

Advertisement

 

The company’s new division, DeepMind Health, includes physician staff members to help guide research and development for smart medical devices and other healthcare technology. One of those physicians is DominicKing, MD, co-founder of U.K.-based startup Hark, which was purchased by DeepMind.

 

So far, DeepMind Health has introduced software called Streams in a pilot project with RoyalFreeHospital in London. Streams is designed to get medical results to clinicians faster, in some instances within seconds, Royal Free Hospital’s associate medical director told BloombergBusiness.

 

Alphabet, Google’s parent company, also recently backed Calico, an anti-aging company, is also putting a growing emphasis on the scientific research Google conducts.

 

“The ambition of DeepMind Health in the long term is to deliver tools that clinicians can use to make sense of the huge inflows of information that they’re overwhelmed by,” Mustafa Suleyman, co-founder of DeepMind, told BloombergBusiness.

More articles on health IT:

NIH names Verily, Vanderbilt to head precision medicine pilot
Google-back UK ‘robot doctor’ startup nets largest Series A funding in Europe’s history at $25M
Alphabet ousts Apple as most valuable company in the world

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Public Health

Advertisement

Comments are closed.